|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||95.71 - 98.41|
|52 Week Range||78.97 - 104.82|
|PE Ratio (TTM)||27.16|
|Earnings Date||Apr 19, 2018|
|Forward Dividend & Yield||0.64 (0.64%)|
|1y Target Est||108.47|
In 2018, Dentsply Sirona (XRAY) is expected to register flat margins or a decline in EBIT (earnings before income and tax) margin. By comparison, peers Danaher (DHR), Zimmer Biomet Holdings (ZBH), and Integra Lifesciences (IART) registered operating margin growth of 16.5%, 10.3%, and 3.7%, respectively, in fiscal 2017. The company currently has an attractive margin profile and registered a gross margin of ~55% of the company’s total sales in 2017. As the company evaluated its impairment analysis results, it saw a significant impairment charge in 2017.
Dentsply Sirona (XRAY) reported its 2018 guidance during the company’s 4Q17 and fiscal 2017 earnings results release on March 2, 2018. For fiscal 2018, Dentsply Sirona has an adjusted EPS (earnings per share) guidance range of $2.70–$2.80, representing a growth rate of 8% to 11%. Dentsply Sirona expects to generate flat margins or a decline in its gross margin and operating margin due to currency headwinds, and the negative impact of the reductions in dealer equipment levels.
Although Dentsply Sirona (XRAY) has given a disappointing performance recently, the company is still confident that it can gain a higher market share going forward. The company’s strategic growth plan consists of five key priorities meant to counteract the impact of the significant impairment charges it saw in 2017 (stemming from the merger of Dentsply International and Sirona Dental Systems in February 2016). Below, we’ll discuss why Dentsply Sirona is so confident that it can gain a higher market share in 2018 and 2019.
WASHINGTON, D.C., March 19, 2018 /PRNewswire/ -- Danaher Corporation (DHR) announced today that it will webcast its quarterly earnings conference call for the first quarter 2018 on Thursday, April 19, 2018 beginning at 8:00 a.m. ET and lasting approximately 1 hour. The call and an accompanying slide presentation will be webcast on the "Investors" section of Danaher's website, www.danaher.com, under the subheading "Events & Presentations." A replay of the webcast will be available shortly after the conclusion of the presentation and will remain available until the next quarterly earnings call. You can access the conference call by dialing 888-882-4478 within the U.S. or +1 323-794-2149 outside the U.S. a few minutes before 8:00 a.m. ET and notifying the operator that you are dialing in for Danaher's earnings conference call (access code 1818726).
In 4Q17, Dentsply Sirona (XRAY) started reporting its operations under two segments, after a shift to three segments in fiscal 3Q17. The company had a two segment operational structure prior to 3Q17, but the new two-segment structure has some differences, which we’ll discuss below.
In the past six months, the number of analysts covering W.R. Grace (GRA) has fallen from 14 to the present 11. Among them, 82% of analysts have recommended “buys,” 18% have recommended “holds,” and none have recommended “sells” on the stock. Analysts’ consensus indicates a target price of $83.00 for W.R. Grace, which implies a return potential of 25.0% over its closing price as of March 14, 2018.
Dentsply Sirona (XRAY) is one of the leading dental technology, equipment, and consumables providers in the United States. But the company has been going through some tough times following the merger of Sirona Dental Systems and Dentsply International and the subsequent formation of Dentsply Sirona in February 2016. Dentsply Sirona released its 4Q17 and fiscal 2017 earnings results on March 2, 2018. In this first part of our 14-part series on the company, we’ll take a look at what Wall Street is recommending for Dentsply Sirona now as well as the analyst consensus 12-month target price for the company’s stock.
Glenstone, the contemporary art museum established more than a decade ago in a rural section of Montgomery County, will open its long-planned expansion Oct. 4. The project includes 240,000 square feet of new space and will make Glenstone one of the world’s largest private museums . The expansion includes new gallery spaces called The Pavilions with a bookstore as well as a new arrival hall and two cafes. The Pavilions will offer 50,000 square feet of additional exhibition space, a nearly six-fold increase from the 9,000 square feet in Glenstone’s original museum building.
Stock Monitor: Raven Industries Post Earnings Reporting LONDON, UK / ACCESSWIRE / March 13, 2018 / Active-Investors.com has just released a free research report on Danaher Corp. (NYSE: DHR ). If you want ...
The industrial conglomerate, following in the footsteps of its highly acquisitive former parent, is loading up a war chest for mergers and acquisitions.
CEO John Flannery reiterated an intention to restructure the beleaguered industrial company and release value for shareholders -- and the nomination of Larry Culp is a major plus.
Industrial name Fortive Corp (NYSE: FTV ) has been a consistent outperformer since its spin-off from Danaher Corporation (NYSE: DHR ), according to JPMorgan. The Analyst JPMorgan analyst Stephen Tusa ...
D.C.-based Danaher Corp. is buying Integrated DNA Technologies, a privately held supplier of custom nucleic acids based in Coralville, Iowa. IDT’s primary business is manufacturing and supplying DNA and RNA oligonucleotides to biotech, agriculture and academic research customers. “IDT expands our presence into the highly attractive genomics market and will help play a central role in accelerating our customers' research and time to market as they develop critical diagnostic tests and potential life-saving therapies,” Danaher Executive Vice President Rainer Blair said in a statement.
IDT's primary business is the manufacturing of high-quality, custom DNA and RNA oligonucleotides serving customers in the academic and biopharmaceutical research, biotechnology, agriculture, clinical diagnostics, and pharmaceutical development end markets. Founded in 1987 by Joseph Walder, MD, PhD, IDT has grown to become a leader in its served markets with more than 1,200 employees and over 100,000 customers worldwide.